<?xml version="1.0" encoding="UTF-8"?>
<?xml-stylesheet type="text/xsl" media="screen" href="/~d/styles/rss2full.xsl"?><?xml-stylesheet type="text/css" media="screen" href="http://feeds.sciencedaily.com/~d/styles/itemcontent.css"?><rss xmlns:media="http://search.yahoo.com/mrss/" xmlns:feedburner="http://rssnamespace.org/feedburner/ext/1.0" version="2.0">
	<channel>
		<title>Lung Cancer News -- ScienceDaily</title>
		<link>https://www.sciencedaily.com/news/health_medicine/lung_cancer/</link>
		<description>Information about lung cancer symptoms and treatments. Explore the latest medical research on cancers including experimental treatments.</description>
		<language>en-us</language>
		<pubDate>Sun, 06 Mar 2016 23:08:10 EST</pubDate>
		<lastBuildDate>Sun, 06 Mar 2016 23:08:10 EST</lastBuildDate>
		<ttl>60</ttl>
		<image>
			<title>Lung Cancer News -- ScienceDaily</title>
			<url>https://www.sciencedaily.com/images/scidaily-logo-rss.png</url>
			<link>https://www.sciencedaily.com/news/health_medicine/lung_cancer/</link>
			<description>For more science news, visit ScienceDaily.</description>
		</image>
		
		<atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="self" type="application/rss+xml" href="http://feeds.sciencedaily.com/sciencedaily/health_medicine/lung_cancer" /><feedburner:info uri="sciencedaily/health_medicine/lung_cancer" /><atom10:link xmlns:atom10="http://www.w3.org/2005/Atom" rel="hub" href="http://pubsubhubbub.appspot.com/" /><feedburner:emailServiceId>sciencedaily/health_medicine/lung_cancer</feedburner:emailServiceId><feedburner:feedburnerHostname>https://feedburner.google.com</feedburner:feedburnerHostname><item>
			<title>Dietary glycemic index linked to lung cancer risk in select populations</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/kPPmkltNB28/160304091915.htm</link>
			<description>Consuming a diet with a high glycemic index, a classification of how rapidly carbohydrates elevate blood sugar levels, was independently associated with an increased risk of developing lung cancer in non-Hispanic whites, according to a new epidemiologic study.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/kPPmkltNB28" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Fri, 04 Mar 2016 09:19:15 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/03/160304091915.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/03/160304091915.htm</feedburner:origLink></item>
		<item>
			<title>Cancer expert says public health, prevention measures are key to defeating cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/yFpc4F9vqns/160303145920.htm</link>
			<description>Is investment in research to develop new treatments the best approach to controlling cancer? Many people believe that the time is right for another big push to defeat cancer, including President Obama, who called for a major cancer-fighting campaign in his final State of the Union address. But in a new paper, this kind of effort will never cure cancer without public health and prevention.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/yFpc4F9vqns" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 03 Mar 2016 14:59:20 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/03/160303145920.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/03/160303145920.htm</feedburner:origLink></item>
		<item>
			<title>Differences in type of small protein may further elucidate lung cancer risk in African Americans</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/U3TTqpOQLyM/160302084559.htm</link>
			<description>Research shows differences in a certain type of small protein vary by race and may contribute differently to the development of lung cancer in African Americans and European Americans.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/U3TTqpOQLyM" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 02 Mar 2016 08:45:59 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/03/160302084559.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/03/160302084559.htm</feedburner:origLink></item>
		<item>
			<title>Cancer patients with limited finances are more likely to have increased symptoms and poorer quality of life</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/NZTrw2t_9Ck/160229182540.htm</link>
			<description>If you're a lung or colorectal cancer patient, what's in your wallet could determine your level of suffering and quality of life during treatment, according to a new study.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/NZTrw2t_9Ck" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 29 Feb 2016 18:25:40 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160229182540.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160229182540.htm</feedburner:origLink></item>
		<item>
			<title>Metabolic phenotyping of blood plasma allows for the detection of lung cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/lR_N1PWdfUs/160229140130.htm</link>
			<description>Metabolic phenotyping of blood plasma by proton nuclear magnetic resonance identified unique metabolic biomarkers specific to lung cancer patients and allowed for the accurate identification of a cohort of patients with early and late-stage lung cancer.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/lR_N1PWdfUs" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 29 Feb 2016 14:01:30 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160229140130.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160229140130.htm</feedburner:origLink></item>
		<item>
			<title>Research on treatments for advanced ovarian cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/kxosJtFr7yU/160226173202.htm</link>
			<description>New research supports the use of weekly chemotherapy without bevacizumab in treating advanced ovarian cancer.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/kxosJtFr7yU" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Fri, 26 Feb 2016 17:32:02 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160226173202.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160226173202.htm</feedburner:origLink></item>
		<item>
			<title>Understanding the role of human polyomaviruses in cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/f_n30ei5zRQ/160225105241.htm</link>
			<description>A new method to screen tumor samples for the presence of any human polyomavirus has been created by a team of researchers. Their study found no evidence for the involvement of human polyomaviruses in the development of these cancers and helps to resolve questions in the field about whether viruses related to Merkel cell polyomavirus contribute to cancer.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/f_n30ei5zRQ" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 25 Feb 2016 10:52:41 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160225105241.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160225105241.htm</feedburner:origLink></item>
		<item>
			<title>Unconventional treatment strategy controls -- rather than eradicates -- cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/y4Bn4COXCn0/160224145608.htm</link>
			<description>Can we learn to live with--rather than kill--cancer? A new study suggests that frequent, low-dose chemotherapy that keeps tumor growth under control may be more effective than standard high-dose chemotherapy that seeks to eradicate cancer cells completely.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/y4Bn4COXCn0" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2016/02/160224145608.jpg" height="280" width="300" />
			<pubDate>Wed, 24 Feb 2016 14:56:08 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160224145608.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160224145608.htm</feedburner:origLink></item>
		<item>
			<title>Autoantibodies may help detect lung cancer earlier</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/fBpxaAuetrc/160217140321.htm</link>
			<description>Preliminary research has identified autoantibodies, immune proteins found in the blood specific for one's own proteins, that can potentially detect lung cancer early by distinguishing between smokers with or without lung cancer and also discriminate between lung cancer and low-dose computed tomography (LDCT) detected non-cancerous lung lesions.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/fBpxaAuetrc" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 17 Feb 2016 14:03:21 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160217140321.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160217140321.htm</feedburner:origLink></item>
		<item>
			<title>Pairing pain medicine with metal ions to battle cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/jULf5cz2ono/160217130711.htm</link>
			<description>Fighting chemoresistant cancer remains a huge challenge that scientists are tackling from as many angles as they can. One alternative approach involves pairing two groups of compounds -- pain medicine and metal ions -- that have individually shown promise as anti-cancer agents. Scientists now report that combining the two led to new compounds that could destroy drug-resistant cancer cells and leave most normal cells alone in lab tests.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/jULf5cz2ono" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 17 Feb 2016 13:07:11 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160217130711.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160217130711.htm</feedburner:origLink></item>
		<item>
			<title>Immune-targeting drug combo shows promise for lung cancer patients</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/BFDqLqx5tpc/160217130701.htm</link>
			<description>Lung cancer is the most common cause of cancer-related death in the United States resulting in more than 158,000 deaths each year. Investigators initiated a multicenter phase 1b clinical trial to determine the safety and efficacy of a new drug combination for non-small cell lung cancer that stimulates a patient's immune system to target and kill cancer cells.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/BFDqLqx5tpc" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 17 Feb 2016 13:07:01 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160217130701.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160217130701.htm</feedburner:origLink></item>
		<item>
			<title>Cancer study is 'paradigm shift' in cause of tumor formation</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/1YYm4FX22eE/160217113640.htm</link>
			<description>A gene that may provide a new source of potential drug targets for tumors that arise in pulmonary tuberous sclerosis complex (TSC) has been found by a pair of investigators. The discovery may change what is known about tumor formation and help to slow or halt tumor growth, therefore having broader implications in cancer research.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/1YYm4FX22eE" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 17 Feb 2016 11:36:40 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160217113640.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160217113640.htm</feedburner:origLink></item>
		<item>
			<title>Some chemotherapy drugs may improve tumor response to immune checkpoint therapy</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/hQdgArhM2E8/160216181059.htm</link>
			<description>The use of certain traditional chemotherapy drugs may expand the number of tumors that respond to one of today's most promising cancer therapies -- immune checkpoint blockade. Researchers report that inducing the infiltration of cytotoxic T cells into lung tumors sensitized otherwise unresponsive tumors to checkpoint blockade in animal models.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/hQdgArhM2E8" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 16 Feb 2016 18:10:59 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160216181059.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160216181059.htm</feedburner:origLink></item>
		<item>
			<title>Genome studies can help identify lifestyle risks for diseases</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/BVEM4INu1HY/160212102344.htm</link>
			<description>A type of study commonly used to pinpoint genetic variants associated with diseases can also be used to identify the lifestyle predictors that increase the risk of a disease -- something that is often overlooked in genetic studies.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/BVEM4INu1HY" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Fri, 12 Feb 2016 10:23:44 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160212102344.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160212102344.htm</feedburner:origLink></item>
		<item>
			<title>Potential therapy for most aggressive type of lung cancer in preclinical models</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/MuiJK1LvP9Y/160211142232.htm</link>
			<description>The specific combination of the drugs dasatinib and demcizumab impairs the growth of KRAS-driven lung tumors, the most aggressive sub-type and with the lowest survival rates. The research was conducted on mouse models and samples of human tumors. The experts are confident they can soon start clinical trials which will make it possible to transfer the discoveries to cancer patients.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/MuiJK1LvP9Y" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2016/02/160211142232.jpg" height="238" width="300" />
			<pubDate>Thu, 11 Feb 2016 14:22:32 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160211142232.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160211142232.htm</feedburner:origLink></item>
		<item>
			<title>Potential targeted therapy for lung cancer identified using fly model</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/UixwsTMTsbE/160201142139.htm</link>
			<description>A drug approved by the Food and Drug Administration (FDA) for melanoma in combination with a common cholesterol-lowering drug may show promise in controlling cancer growth in patients with non-small cell lung cancer (NSCLC), according to new research.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/UixwsTMTsbE" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 01 Feb 2016 14:21:39 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/02/160201142139.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/02/160201142139.htm</feedburner:origLink></item>
		<item>
			<title>In lung cancer, not all HER2 alterations are created equal</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/zjn_cc6KBN8/160128113847.htm</link>
			<description>Study shows two distinct causes of HER2 activation in lung cancer: mutation of the gene and amplification of the gene. In patient samples of lung adenocarcinoma, 3 percent were found to have HER2 amplification and another 3 percent were found to have HER2 mutation. No samples were found to have both. These distinct causes of HER2 positivity imply the use of different targeted therapies to combat these related but possibly distinct diseases.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/zjn_cc6KBN8" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 28 Jan 2016 11:38:47 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/01/160128113847.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/01/160128113847.htm</feedburner:origLink></item>
		<item>
			<title>Important falls in death rates from leukemia in Europe predicted for 2016</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/wEROLwSaGDk/160127052606.htm</link>
			<description>Death rates from leukemia among people of all ages in Europe are falling, according to the latest predictions for European cancer deaths in 2016. The study by researchers in Italy, Switzerland and the USA looked at cancer death rates in the EU 28 member states as a whole and also in the six largest countries -- France, Germany, Italy, Poland, Spain and the UK -- for all cancers, and some individual cancers in men and women.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/wEROLwSaGDk" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 27 Jan 2016 05:26:06 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/01/160127052606.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/01/160127052606.htm</feedburner:origLink></item>
		<item>
			<title>Cancer in China</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/o9gTytFHVeQ/160126162209.htm</link>
			<description>There were 4.3 million new cancer cases and more than 2.8 million cancer deaths in China in 2015, with lung cancer the most common cancer and the leading cause of cancer death in China, a new report estimates.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/o9gTytFHVeQ" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 26 Jan 2016 16:22:09 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/01/160126162209.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/01/160126162209.htm</feedburner:origLink></item>
		<item>
			<title>E-cigarette vapor boosts superbugs and dampens immune system</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/auLU5U5ymhc/160126143759.htm</link>
			<description>E-cigarettes are toxic to human airway cells, suppress immune defenses and alter inflammation, while at the same time boosting bacterial virulence, new data suggest. In lab and mouse experiments, exposure promotes bacterial virulence and inflammation, while blocking the bodyâs ability to fight infection, the investigators report.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/auLU5U5ymhc" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 26 Jan 2016 14:37:59 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/01/160126143759.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/01/160126143759.htm</feedburner:origLink></item>
		<item>
			<title>Heavy smokers who quit more than 15 years ago still at high risk for lung cancer and should be screened</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/LFf0fDrqOJA/160126143757.htm</link>
			<description>Expanding lung cancer screening to include people who quit smoking more than 15 years ago could detect more cases and further reduce associated mortality, according to a study.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/LFf0fDrqOJA" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 26 Jan 2016 14:37:57 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/01/160126143757.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/01/160126143757.htm</feedburner:origLink></item>
		<item>
			<title>New biomarkers may influence drug design, alternative treatments of cancer, study shows</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/HJoDqRrzH9k/160121121820.htm</link>
			<description>Researchers have discovered gene-targets (biomarkers) that may enable alternative treatments or the potential design of new drugs that target metastasis-promoting tumor genes.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/HJoDqRrzH9k" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 21 Jan 2016 12:18:20 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/01/160121121820.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/01/160121121820.htm</feedburner:origLink></item>
		<item>
			<title>New findings may enhance PARP inhibitors therapy in breast cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/UhKiwuJTyMs/160118134538.htm</link>
			<description>PARP inhibitors, an emerging class of drugs being studied in cancer clinical trials, may be enhanced by combining them with inhibitors targeting an oncogene known as c-MET which is overexpressed in many cancers, new research shows.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/UhKiwuJTyMs" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 18 Jan 2016 13:45:38 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/01/160118134538.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/01/160118134538.htm</feedburner:origLink></item>
		<item>
			<title>Researchers kill drug-resistant lung cancer with 50 times less chemo</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/qQ8SmBPM2ys/160114113632.htm</link>
			<description>The cancer drug paclitaxel just got more effective. For the first time, researchers have packaged it in containers derived from a patient's own immune system, protecting the drug from being destroyed by the body's own defenses and bringing the entire payload to the tumor.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/qQ8SmBPM2ys" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2016/01/160114113632.jpg" height="200" width="300" />
			<pubDate>Thu, 14 Jan 2016 11:36:32 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/01/160114113632.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/01/160114113632.htm</feedburner:origLink></item>
		<item>
			<title>Stage increase in lung cancer more frequent after open vs. closed thoracic surgery</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/vXRLo5mlRRE/160111135614.htm</link>
			<description>An increase in the stage of non-small cell lung cancer due to cancer positive lymph node discovery was more common following open chest surgery for lung lobe removal of early stage lung cancer compared to the closed chest procedure known as video assisted thoracic surgery, report scientists.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/vXRLo5mlRRE" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 11 Jan 2016 13:56:14 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/01/160111135614.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/01/160111135614.htm</feedburner:origLink></item>
		<item>
			<title>Researchers find shared molecular response to tobacco smoke, indoor air pollution</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/n5nvonSSVb0/160111135237.htm</link>
			<description>Exposure to certain household air pollutants may cause some of the same molecular changes as smoking cigarettes, report scientists. The study, conducted on non-smoking women living in rural China who burn smoky (bituminous) coal for heating and cooking is the first to identify genomic alterations that result from exposure to smoky coal.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/n5nvonSSVb0" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 11 Jan 2016 13:52:37 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/01/160111135237.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/01/160111135237.htm</feedburner:origLink></item>
		<item>
			<title>Smokers diagnosed with pneumonia found to have higher risk of lung cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/FbX6PgY4cBc/160107104811.htm</link>
			<description>Screening heavy smokers admitted to the hospital with community-acquired pneumonia could facilitate the early diagnosis of lung cancer and thereby reduce the incidence of mortality, a new report suggests.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/FbX6PgY4cBc" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 07 Jan 2016 10:48:11 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/01/160107104811.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/01/160107104811.htm</feedburner:origLink></item>
		<item>
			<title>Lung cancer clinical trial finds lung function without additional imaging</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/A52ZoVU9JsE/160106215845.htm</link>
			<description>A clinical trial is evaluating a new method for pinpointing and sparing healthy lung tissue during lung cancer radiotherapy. The group is applying advanced image analysis techniques to 4D CT scans already performed as a standard step in targeting lung cancer radiotherapy, to map areas of lung function without additional testing.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/A52ZoVU9JsE" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 06 Jan 2016 21:58:45 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/01/160106215845.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/01/160106215845.htm</feedburner:origLink></item>
		<item>
			<title>Statins could be effective against small cell lung cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/sK1uHIViG3Y/160106215841.htm</link>
			<description>Researchers have found that statins could be an effective therapeutic against metastatic small cell lung cancer. The study of 876 late-stage SCLC patients, showed that statins, a class of drugs primarily used to lower cholesterol in patients at risk for heart disease, appeared to provide an increase in overall survival.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/sK1uHIViG3Y" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 06 Jan 2016 21:58:41 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/01/160106215841.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/01/160106215841.htm</feedburner:origLink></item>
		<item>
			<title>Three hits to fight lung cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/hhMnCvJob2E/160104080028.htm</link>
			<description>Cancers with KRAS-related gene mutations might benefit from a triple therapy with two experimental drugs plus radiation therapy, a new study in mice has shown.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/hhMnCvJob2E" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 04 Jan 2016 08:00:28 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2016/01/160104080028.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2016/01/160104080028.htm</feedburner:origLink></item>
		<item>
			<title>Personalizing cancer therapies may combat resistance to targeted therapy drugs</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/dAYGuoy8XxM/151223221343.htm</link>
			<description>American physicians report the case of a patients whose lung cancer was re-sensitized to crizotinib, a first-generation targeted therapy drug, by a mutation conferring resistance to a more selective, next-generation ALK inhibitor.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/dAYGuoy8XxM" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 23 Dec 2015 22:13:43 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/12/151223221343.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/12/151223221343.htm</feedburner:origLink></item>
		<item>
			<title>Low-dose CT screening effective in detecting lung cancer at early stage in longtime smokers</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/tov8hzOz6PM/151222084724.htm</link>
			<description>Low-dose CT screening is recommended by the U.S. Preventive Services Task Force and numerous other organizations for people 55 and over with no symptoms of lung cancer who have smoked the equivalent of one pack of cigarettes a day for 30 years and who still smoke or have quit within the past 15 years. New research shows that this is an effective way to detect lung cancer.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/tov8hzOz6PM" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2015/12/151222084724.jpg" height="198" width="300" />
			<pubDate>Tue, 22 Dec 2015 08:47:24 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/12/151222084724.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/12/151222084724.htm</feedburner:origLink></item>
		<item>
			<title>Afatinib a better choice for EGFR-mutated lung cancer in first-line treatment</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/vBoYJO-wygQ/151221095432.htm</link>
			<description>Patients with EGFR-activating mutations in advanced lung cancer seem to benefit more from afatinib than gefitinib as first-line treatment, researchers report.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/vBoYJO-wygQ" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 21 Dec 2015 09:54:32 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/12/151221095432.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/12/151221095432.htm</feedburner:origLink></item>
		<item>
			<title>Immunotherapy drug more effective than chemotherapy in most patients with advanced lung cancer, study finds</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/mxRuZQE71P0/151219144929.htm</link>
			<description>A new study has found immunotherapy to be more effective than chemotherapy in treating most previously treated patients with advanced lung cancer, and demonstrated effectiveness in a wider population of people than previously known to benefit from the therapy.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/mxRuZQE71P0" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Sat, 19 Dec 2015 14:49:29 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/12/151219144929.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/12/151219144929.htm</feedburner:origLink></item>
		<item>
			<title>Researchers develop new method for looking into the lungs</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/Dd0cd7uJEPM/151218110048.htm</link>
			<description>For the first time, researchers have succeeded in producing 3-D images showing oxygen and carbon dioxide transport in the lungs. The new method provides hope for better treatment of COPD and lung cancer.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/Dd0cd7uJEPM" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Fri, 18 Dec 2015 11:00:48 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/12/151218110048.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/12/151218110048.htm</feedburner:origLink></item>
		<item>
			<title>Younger age associated with increased likelihood of targetable genotype in lung cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/75afN_gf8bg/151217114945.htm</link>
			<description>Patients younger than 50 diagnosed with non-small-cell lung cancer had a higher likelihood of having a targetable genomic alteration for which therapies exist, according to an article.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/75afN_gf8bg" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 17 Dec 2015 11:49:45 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/12/151217114945.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/12/151217114945.htm</feedburner:origLink></item>
		<item>
			<title>When cancer of unknown origin strikes, patient's family members face increased risk</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/CnMmBvc-xaU/151217114943.htm</link>
			<description>Cancer usually begins in one location and then spreads, but in 3 percent to 5 percent of cancer patients, the tissue where a cancer begins is unknown. Family members of patients with cancers of unknown origin have a higher risk for getting those and other types of cancers, suggests a new study.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/CnMmBvc-xaU" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 17 Dec 2015 11:49:43 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/12/151217114943.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/12/151217114943.htm</feedburner:origLink></item>
		<item>
			<title>Non-small cell lung cancers can be sorted in clusters by endocytic changes</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/JGB44J-6E3E/151211124301.htm</link>
			<description>Endocytosis is not normal in cancer cells but how dysregulated the process is in cancer cells has just been revealed by researchers who used three endocytic pathways as markers to sort out 29 non-small cell lung cancer lines into two distinct clusters characterized by their endocytic dysfunction.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/JGB44J-6E3E" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Fri, 11 Dec 2015 12:43:01 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/12/151211124301.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/12/151211124301.htm</feedburner:origLink></item>
		<item>
			<title>Researchers identify biomarker of early lung cancer that may increase survival</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/QecEHt3rfU0/151203140005.htm</link>
			<description>Researchers have identified a biomarker that detects the most common lung cancer in its earliest stage. The discovery could one day change how long lung cancer patients live.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/QecEHt3rfU0" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 03 Dec 2015 14:00:05 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/12/151203140005.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/12/151203140005.htm</feedburner:origLink></item>
		<item>
			<title>Genetic mutations differ within a single tumor</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/sGSBBsAyTSg/151202124646.htm</link>
			<description>When researchers looked at different areas within an individual rectal cancer sample, they found cases in which each area contained different genetic mutations. The findings could have significant implications for treatment recommendations.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/sGSBBsAyTSg" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 02 Dec 2015 12:46:46 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/12/151202124646.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/12/151202124646.htm</feedburner:origLink></item>
		<item>
			<title>Stopping ovarian cancer in its tracks: Antibody may help patients heal themselves</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/Otdh7Dcj5LE/151201114755.htm</link>
			<description>In a first, researchers show the potential a PD-1 antibody, nivolumab, has in fighting the disease. Nivolumab, an inhibitory antibody for PD-1, has shown efficacy in several types of malignancies including melanoma, kidney cancer, and non-small cell lung cancer.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/Otdh7Dcj5LE" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2015/12/151201114755.jpg" height="180" width="300" />
			<pubDate>Tue, 01 Dec 2015 11:47:55 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/12/151201114755.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/12/151201114755.htm</feedburner:origLink></item>
		<item>
			<title>Tumor-suppressor p53 regulates protein that stifles immune attack on cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/NScrmB-I3XQ/151120182831.htm</link>
			<description>A crucial tumor-thwarting gene protects an immune attack against lung cancer by blocking the key to an off switch on T cells, the customized warriors of the immune system, a team of researchers reports.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/NScrmB-I3XQ" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Fri, 20 Nov 2015 18:28:31 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/11/151120182831.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/11/151120182831.htm</feedburner:origLink></item>
		<item>
			<title>Circulating small cell lung cancer cells successfully cultivated for the very first time</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/CHOgxkpLhz0/151119103547.htm</link>
			<description>Most cases of small cell lung cancer are only diagnosed after the tumor has already formed metastases. Until now it has not been possible to investigate the reasons for this rapid metastasis, because of a lack of sufficient tumor material from patients. Now, the group of researchers has succeeded in creating infinitely reproducing tissue cultures.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/CHOgxkpLhz0" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 19 Nov 2015 10:35:47 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/11/151119103547.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/11/151119103547.htm</feedburner:origLink></item>
		<item>
			<title>Receiving curative lung cancer surgery varies by state</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/v9I9Ir1JCa8/151113105617.htm</link>
			<description>The likelihood of receiving curative-intent surgery for patients with early-stage non-small cell lung cancer varies substantially from state to state, according to new data.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/v9I9Ir1JCa8" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Fri, 13 Nov 2015 10:56:17 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/11/151113105617.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/11/151113105617.htm</feedburner:origLink></item>
		<item>
			<title>Engineers develop 'killer cells' to destroy cancer in lymph nodes</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/jwqLErJWrog/151113051121.htm</link>
			<description>Biomedical engineers have developed specialized white blood cells -- dubbed 'super natural killer cells' -- that seek out cancer cells in lymph nodes with only one purpose: destroy them. This breakthrough halts the onset of metastasis, according to the research team.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/jwqLErJWrog" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Fri, 13 Nov 2015 05:11:21 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/11/151113051121.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/11/151113051121.htm</feedburner:origLink></item>
		<item>
			<title>Blood sample new way of detecting cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/69AGTkY2_KY/151112123708.htm</link>
			<description>A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analyzing a sample equivalent to one drop of blood. Using this new method for blood-based RNA tests of blood platelets, researchers have been able to identify cancer with 96 per cent accuracy, scientists report.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/69AGTkY2_KY" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2015/11/151112123708.jpg" height="200" width="300" />
			<pubDate>Thu, 12 Nov 2015 12:37:08 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/11/151112123708.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/11/151112123708.htm</feedburner:origLink></item>
		<item>
			<title>Link found between genetic mutations, proliferation, immune surveillance in lung cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/2Hf7XUcJME8/151111172520.htm</link>
			<description>There are four gene mutations (KRAS, TP53, STK11, and EGFR) that most commonly occur in lung cancer; however, there are limited effective therapies to target these mutations. With this in mind, researchers performed an extensive genetic analysis of lung cancer specimens to unravel how mutations in the two of those genes (TP53 and STK11) contribute to the biology of lung cancer and patient outcomes.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/2Hf7XUcJME8" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 11 Nov 2015 17:25:20 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/11/151111172520.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/11/151111172520.htm</feedburner:origLink></item>
		<item>
			<title>Lung cancer surgery can be beneficial for high-risk patients with early stage disease</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/ZPwmi5E4b0A/151110083226.htm</link>
			<description>Surgical lung resection, in which part of a lung is removed, can be a safe and effective treatment option for high-risk patients with early stage lung cancer, say researchers.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/ZPwmi5E4b0A" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 10 Nov 2015 08:32:26 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/11/151110083226.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/11/151110083226.htm</feedburner:origLink></item>
		<item>
			<title>Simple test predicts response to chemotherapy in lung cancer patients</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/6faJKS4UKqU/151103112448.htm</link>
			<description>Adenocarcinoma patients who undergo chemotherapy and surgery experience significantly improved survival rates when their tumor is lacking the retinoblastoma tumor suppressor protein, new research shows. This new information is very useful as it may predict which patients will respond best to chemotherapy.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/6faJKS4UKqU" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 03 Nov 2015 11:24:48 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/11/151103112448.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/11/151103112448.htm</feedburner:origLink></item>
		<item>
			<title>Molecular 'brake' stifles human lung cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/driUiELfWjw/151102163713.htm</link>
			<description>By testing over 4,000 genes in human tumors, a research team uncovered an enzyme responsible for suppressing a common and deadly lung cancer. This enzyme, called EphA2, normally polices a gene responsible for tissue growth. But when EphA2 is mutated, the team discovered, cellular systems can run amok and quickly develop tumors.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/driUiELfWjw" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2015/11/151102163713.jpg" height="200" width="300" />
			<pubDate>Mon, 02 Nov 2015 16:37:13 EST</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/11/151102163713.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/11/151102163713.htm</feedburner:origLink></item>
		<item>
			<title>New treatment option for nonfunctional neuroendocrine tumours of the lung, gastrointestinal tract</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/TY7Xc8zlXHQ/151028054912.htm</link>
			<description>The efficacy of the agent everolimus in treating nonfunctional neuroendocrine tumours of lung or gastrointestinal origin has been demonstrated by researchers. Progression-free survival of patients was successfully extended by seven months and the risk of progression of the disease fell by 52%. Everolimus was well tolerated and side-effects were consistent with the known profile.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/TY7Xc8zlXHQ" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Wed, 28 Oct 2015 05:49:12 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/10/151028054912.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/10/151028054912.htm</feedburner:origLink></item>
		<item>
			<title>Natural protein cage developed for improved cancer drug delivery</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/qhXvQAdOx1Y/151026174109.htm</link>
			<description>A unique, tiny protein cage has been created by scientists to deliver nasty chemotherapy chemicals directly to cancer cells. Direct delivery could improve treatment and lessen what can be horrendous side effects from toxic drugs.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/qhXvQAdOx1Y" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 26 Oct 2015 17:41:09 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/10/151026174109.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/10/151026174109.htm</feedburner:origLink></item>
		<item>
			<title>Lung cancer specialist brings new treatments, hope to New Mexicans</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/GgEsfkIPOKs/151026093653.htm</link>
			<description>This year, more than 158,000 Americans are expected to die from lung cancer. That's a staggering number: it's more than all the deaths expected from breast, prostate, colon, rectum, bladder and skin cancers combined. But this grim statistic only spurs one lung cancer doctor and scientist to work harder toward a cure.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/GgEsfkIPOKs" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 26 Oct 2015 09:36:53 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/10/151026093653.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/10/151026093653.htm</feedburner:origLink></item>
		<item>
			<title>A subpopulation of white blood cells guards against tumor lung metastasis</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/VG3aJiGRgRM/151022192304.htm</link>
			<description>Among foot soldiers on the immune front line is a subpopulation of white blood cells called "patrolling monocytes," whose job is to cruise the bloodstream, cart off cellular debris, and block invasion of a less benign population of inflammatory cells. Now, a study illustrates that patrolling monocytes may also play an anti-cancer role, particularly in the lung.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/VG3aJiGRgRM" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2015/10/151022192304.jpg" height="314" width="300" />
			<pubDate>Thu, 22 Oct 2015 19:23:04 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/10/151022192304.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/10/151022192304.htm</feedburner:origLink></item>
		<item>
			<title>Biologists unravel drug-resistance mechanism in tumor cells</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/CKggc0A3eTU/151022124534.htm</link>
			<description>Cancer biologists have discovered that targeting the RNA-binding protein that promotes drug-resistance could lead to better cancer therapies.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/CKggc0A3eTU" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 22 Oct 2015 12:45:34 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/10/151022124534.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/10/151022124534.htm</feedburner:origLink></item>
		<item>
			<title>A new way to starve lung cancer?</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/iPetpS6EAvA/151020121129.htm</link>
			<description>Scientists have identified a new way to stop the growth of lung cancer cells, by blocking their ability to use alternative sources of nutrition. The discovery was made possible by identifying the metabolic programs used by cancer cells to fuel their growth. The findings point to possible new avenues for treating lung cancer, which is the second most common cancer and accounts for over one-quarter of all cancer-related deaths.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/iPetpS6EAvA" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Tue, 20 Oct 2015 12:11:29 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/10/151020121129.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/10/151020121129.htm</feedburner:origLink></item>
		<item>
			<title>Orange lichens are potential source for anticancer drugs</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/fB64yObAmCM/151019122924.htm</link>
			<description>An orange pigment found in lichens and rhubarb called parietin may have potential as an anti-cancer drug because it interferes with the metabolic enzyme 6PGD, scientists have discovered.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/fB64yObAmCM" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Mon, 19 Oct 2015 12:29:24 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/10/151019122924.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/10/151019122924.htm</feedburner:origLink></item>
		<item>
			<title>For lung cancer patients, IMRT associated with lesser side effects, better tolerance of chemotherapy, compared to conventional radiation therapy</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/nz5_EDS578U/151018223020.htm</link>
			<description>An analysis of an international, cooperative-led trial of patients with locally advanced non-small cell lung cancer has shown that those who received intensity modulated radiation therapy had less severe lung toxicity and were able to better tolerate their chemotherapy, compared to patients who received 3-D conformal radiation therapy.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/nz5_EDS578U" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Sun, 18 Oct 2015 22:30:20 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/10/151018223020.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/10/151018223020.htm</feedburner:origLink></item>
		<item>
			<title>Study reveals high rates of preventable cancers in Indigenous peoples of high-income countries</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/qSHACCXfIns/151015083434.htm</link>
			<description>New research highlights the scale and profile of cancer in indigenous peoples of the USA, Canada, Australia and New Zealand, revealing high rates of often preventable cancers including lung and cervical cancer, emphasizing the need for targeted prevention strategies in these populations.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/qSHACCXfIns" height="1" width="1" alt=""/&gt;</description>
			<pubDate>Thu, 15 Oct 2015 08:34:34 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/10/151015083434.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/10/151015083434.htm</feedburner:origLink></item>
		<item>
			<title>New data may help physicians better understand risk of lung cancer</title>
			<link>http://feeds.sciencedaily.com/~r/sciencedaily/health_medicine/lung_cancer/~3/Qy8UNc8v8dw/151014132408.htm</link>
			<description>Cancer is a leading cause of death worldwide, second only to cardiovascular disease. Lung cancer, the most common form, causes more deaths than breast, prostate and colorectal cancers combined. Now researchers have developed a new scoring system for a common lung cancer diagnostic test that may help physicians better understand the risk for malignancy when evaluating patients.&lt;img src="http://feeds.feedburner.com/~r/sciencedaily/health_medicine/lung_cancer/~4/Qy8UNc8v8dw" height="1" width="1" alt=""/&gt;</description>
			<media:thumbnail url="https://images.sciencedaily.com/2015/10/151014132408.jpg" height="202" width="300" />
			<pubDate>Wed, 14 Oct 2015 13:24:08 EDT</pubDate>
			<guid isPermaLink="false">https://www.sciencedaily.com/releases/2015/10/151014132408.htm</guid>
		<feedburner:origLink>https://www.sciencedaily.com/releases/2015/10/151014132408.htm</feedburner:origLink></item>
	</channel>
</rss><!-- Page successfully written to cache. --><!-- cached Sun, 06 Mar 2016 23:07:01 EST -->
